Alphasize 50wsp
Also known as: Alpha-GPC, α-GPC, AlphaSize®, Alpha-Glycerylphosphorylcholine
Overview
Alpha-Glycerylphosphorylcholine (Alpha-GPC) is a natural choline compound found in the brain and in small amounts in food, widely used as a dietary supplement. It serves as a precursor to acetylcholine, a crucial neurotransmitter vital for memory, learning, and muscle control. Alpha-GPC is primarily utilized for its cognitive-enhancing properties, including improvements in memory, attention, and executive function, and for supporting muscular power output and neuromuscular function. It is applied in sports nutrition and for managing cognitive decline conditions such as Alzheimer’s disease and vascular dementia. AlphaSize® 50WSP is a specific, branded formulation containing 50% alpha-GPC powder, enhanced with anti-caking agents to ensure stability and optimal bioavailability. Research on Alpha-GPC is moderately mature, with multiple randomized controlled trials (RCTs) and some meta-analyses supporting its efficacy, particularly in cognitive impairment and healthy populations.
Benefits
Alpha-GPC offers several evidence-based benefits, primarily in cognitive enhancement and neuromuscular function. For cognition, it has been shown to improve memory, attention, and executive function in both clinical populations (e.g., Alzheimer’s, dementia) and healthy adults. For instance, acute supplementation has improved Stroop test performance in young healthy males with moderate effect sizes (d=0.48–0.61). In clinical settings, dementia and Alzheimer’s patients have shown improved cognition after 3–6 months of treatment. Neuromuscular benefits include increased muscular power output, enhanced muscle fiber recruitment, and improved mind-muscle connection, particularly relevant in sports nutrition. Secondary effects observed include mood elevation and increased motivation, noted in a pilot trial with healthy adults. Alpha-GPC may also aid recovery post-stroke and improve symptoms of vascular dementia. While effect sizes are moderate, clinical significance is more established in dementia than in healthy populations. Acute cognitive improvements can be observed within hours, while chronic benefits in cognitive decline typically manifest over several months.
How it works
Alpha-GPC functions by increasing the synthesis of acetylcholine in the brain, a key neurotransmitter essential for cognitive processes like memory and learning, as well as for muscle contraction. By providing a readily available source of choline, Alpha-GPC enhances cholinergic neurotransmission. This action primarily impacts the central nervous system, improving cognitive functions such as memory, attention, and motivation. It also influences the peripheral nervous system by facilitating muscle activation and neuromuscular communication, thereby enhancing muscular power output. Alpha-GPC is highly bioavailable, and formulations like AlphaSize® 50WSP are designed to be stable and moisture-resistant, ensuring efficient delivery of choline to the brain and other target tissues.
Side effects
Alpha-GPC is generally well-tolerated with a low toxicity profile. Clinical trials have reported no serious adverse effects at doses up to 1200 mg/day for up to 6 months. Common side effects (occurring in >5% of users) are not consistently reported. Uncommon side effects (1–5%) may include mild gastrointestinal discomfort, though this is not frequently observed. Rare side effects (<1%) have not been significantly documented. Potential drug interactions exist with cholinergic drugs; caution is advised when Alpha-GPC is used concurrently with acetylcholinesterase inhibitors (which increase acetylcholine levels) or anticholinergic medications (which block acetylcholine). There are no well-established contraindications, but due to limited data, caution is recommended during pregnancy and lactation. Alpha-GPC has been studied in special populations such as dementia and stroke patients, and it is generally considered safe for healthy adults and athletes within recommended dosages.
Dosage
The minimum effective dose for acute cognitive effects of Alpha-GPC is typically observed at 300–400 mg in single doses. Optimal daily dosage ranges from 300 mg to 1200 mg, depending on the specific indication. For AlphaSize® 50WSP, a serving of 600 mg provides 300 mg of Alpha-GPC. The maximum safe dose, as demonstrated in clinical trials, is up to 1200 mg/day for periods up to 6 months. Acute effects can be noticed within hours, while chronic benefits for cognitive decline require consistent dosing over several months. AlphaSize® 50WSP is a stable powder form; it is generally recommended to take it with food to enhance absorption. While Alpha-GPC is moisture-sensitive, the anti-caking agents in AlphaSize® 50WSP improve its stability. No specific cofactors are required, but general nutritional support is always beneficial.
FAQs
Is AlphaSize® 50WSP different from generic Alpha-GPC?
Yes, AlphaSize® 50WSP is a clinically researched, branded form of Alpha-GPC. It includes anti-caking agents for enhanced stability and bioavailability, which helps prevent degradation and avoids the 'crash' effects sometimes reported with generic versions.
Is Alpha-GPC safe for long-term use?
Clinical trials have shown Alpha-GPC to be safe for use up to 6 months at doses of 1200 mg/day, with no serious adverse events reported. Longer-term safety data is less extensive but current evidence suggests good tolerability.
How quickly will I notice effects from Alpha-GPC?
Acute cognitive improvements can be noticed within hours of a single dose. Effects on mood and motivation may become apparent within a few days, while chronic cognitive benefits, particularly for conditions like dementia, typically require several months of consistent supplementation.
Can Alpha-GPC improve athletic performance?
Evidence suggests Alpha-GPC can improve muscular power output and neuromuscular function, which may benefit athletic performance. However, more extensive research is needed to make definitive claims regarding its overall impact on athletic performance.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8235064/ – This randomized, single-blind pilot trial investigated the effects of 400 mg/day α-GPC in healthy adults over 2 weeks. The study reported increased motivation without significant side effects, suggesting a potential benefit for mood. However, the study's limitations include its small scale, short duration, and single-blind design, warranting further research.
- https://pubmed.ncbi.nlm.nih.gov/39683633/ – This RCT involved young healthy males and examined the acute effects of high and low doses of α-GPC. The results showed significant improvements in Stroop test scores and completion times compared to placebo, with moderate effect sizes. While promising for acute cognitive enhancement, the study was limited to a single acute administration and a narrow range of cognitive domains.
- https://www.holisticbin.com/blogs/news/alphasize-as-told-by-industry-insiders – This source, while not a direct research paper, discusses AlphaSize® and its benefits, citing systematic reviews and meta-analyses that indicate α-GPC improves cognition in Alzheimer’s and vascular dementia patients over 3–6 months. It highlights evidence from double-blind, placebo-controlled trials supporting improvements in memory and thinking skills, acknowledging heterogeneity in study designs.
- https://certifications.nutrasource.ca/certified-products/product?id=CHNT0001 – This source provides information on AlphaSize® 50WSP as a certified product, emphasizing its stability, bioavailability, and the presence of anti-caking agents. It supports the claim that AlphaSize® is a stable, moisture-resistant powder form ensuring consistent delivery of Alpha-GPC, which is crucial for its efficacy.
- https://caringsunshine.com/ingredients/ingredient-alpha-gpc-2/ – This source provides general information about Alpha-GPC, including its role in improving cognition in dementia and Alzheimer’s patients, and its potential benefits for athletes. It supports the understanding that Alpha-GPC is a well-studied ingredient with documented acute and chronic benefits, particularly in high-quality RCTs.
